MRI scan tests new markers for head and neck cancers
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests special MRI scans to find warning signs of cancer that has returned or spread in the head and neck area. It may help doctors see these changes more clearly, which could improve treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have suspected or confirmed cancer that is either recurring or metastatic in the head and neck area
- Plan to receive treatment at Memorial Sloan Kettering (MSK)
- Be able to safely complete MRI without needing anesthesia
- Not be pregnant and be able to cooperate during the MRI scan
- Not have certain MRI safety issues (example: pacemaker, metal clips/implants that are unsafe for MRI) and not have a known allergy to gadolinium contrast
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying how MRI images can help predict response to a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. It aims to improve treatment planning for patients with this type of cancer.
This trial tests a “master protocol” approach to use MRI (a detailed body scan) to help plan radiation treatment for people with cancer. It may help doctors customize radiation more accurately, depending on your specific cancer type.
This study tests MRI scanning and image analysis methods to help doctors plan radiation treatment more accurately and assess how well it’s working. You might help improve how MRI is used for radiation planning and follow-up.
This study uses repeat MRI scans to look for imaging “markers” that may help doctors better understand head and neck squamous cell cancer. It may be most relevant if you are planning curative surgery and/or (chemo)radiotherapy and can safely undergo MRI more than once.
This Phase 1 study tests an investigational MRI scan (hpMRI) to help doctors see how thyroid cancer and other head-and-neck cancers respond to treatment like radiation or other medicines. If you’re eligible, the scan may help track treatment effects more closely, though it’s still being studied for this purpose.
This trial tests a new imaging agent (MPB-2043) that may help doctors see cancer spread to lymph nodes more clearly during an MRI scan. It is for people with head and neck cancer who are planning to have lymph node surgery.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.